Latest News and Press Releases
Want to stay updated on the latest news?
-
March 26, 2026Announcement no. 04 ...
-
LiTime Launches World’s First 12V 200Ah Xtra Mini RV Lithium Battery, Delivering Full 200Ah Capacity in Group 31 Size
-
Product sales and commercial rights revenues in 2025 increased 90% year-over-year to US$82.1 million (RMB574.1 million)Sales of Olverembatinib increased 81% year-over-year to US$62.2 million (RMB435.3...
-
- FDA Grants IND Clearance for SER-252- SER-252 Phase 1b Trial Initiated- Closed Private Placement Financing of up to $30 Million HUNTSVILLE, March 25, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics,...
-
Added top-rated children’s hospitals to QUELIMMUNE™ pediatric Acute Kidney Injury (AKI) customer base Completed enrollment in FDA-mandated QUELIMMUNE SAVE Post-Marketing Registry Exceeded 50%...
-
The U.S. Food and Drug Administration (“FDA”) accepted Celcuity’s New Drug Application (“NDA”) and granted Priority Review with a Prescription Drug User Fee Act (“PDUFA”) goal date of July 17, 2026,...
-
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024 Emrosi™ generated net revenues of $14.7 million during the full-year period after its launch in early April 2025 ...
-
Compagnie Lebon résultats annuels 2025 : hausse du résultat net et de l’ANR. Dividende proposé de 12€, dont 4€ à titre ordinaire et 8€ à titre exceptionnel
-
Aix-en-Provence, 25 March 2026 (6:00 p.m.) HIGHCO: GOOD FINANCIAL PERFORMANCE IN 2025 (ADJUSTED HEADLINE PBIT UP 6.5% TO €8.04 M AND ADJUSTED EPS UP BY 20.8% TO €0.33); STRATEGIC REFOCUSING ON...
-
Quadient FY 2025 results: Revenue of €1,036m, current EBIT margin at 13.0% Ambition raised for Digital, set to become Quadient’s largest and most profitable Solution by 2030 Key highlights ...